These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35416000)

  • 1. Role of secondary sepsis in COVID-19 mortality: Observations on patients with preexisting diabetes mellitus and newly diagnosed hyperglycemia.
    Nair AM; Gopalan S; Rajendran V; Varadaraj P; Marappa L; Pandurangan V; Madhavan S; Mani R; Bhaskar E
    Monaldi Arch Chest Dis; 2022 Apr; 92(4):. PubMed ID: 35416000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between newly diagnosed hyperglycemia/diabetes mellitus, atherogenic index of plasma and obesity in post-COVID-19 syndrome patients.
    Emiroglu C; Dicle M; Yesiloglu C; Gorpelioglu S; Aypak C
    Endocrine; 2024 May; 84(2):470-480. PubMed ID: 38001321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients.
    Charoenngam N; Alexanian SM; Apovian CM; Holick MF
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia as a predictor of in-hospital mortality in elderly patients without diabetes mellitus admitted to a sub-intensive care unit.
    Sleiman I; Morandi A; Sabatini T; Ranhoff A; Ricci A; Rozzini R; Trabucchi M
    J Am Geriatr Soc; 2008 Jun; 56(6):1106-10. PubMed ID: 18482306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 pneumonia in patients with impaired fasting glucose, newly diagnosed diabetes and pre-existing diabetes: a tertiary center experience.
    Boyuk B; Akin S; Aladag N; Isik A; Erman H; Ozgur Y; Topal M; Karademir N; Tomar Uysal B; Ozbilgehan B; Kabaca D; Kalmaz C; Arslan S; Keskin O
    J Investig Med; 2022 Oct; 70(7):1481-1487. PubMed ID: 35654475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia in COVID-19 infection without diabetes mellitus: Association with inflammatory markers.
    Geetha HS; Singh G; Sekar A; Gogtay M; Singh Y; Abraham GM; Trivedi N
    World J Clin Cases; 2023 Feb; 11(6):1287-1298. PubMed ID: 36926123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress hyperglycemia ratio, rather than admission blood glucose, predicts in-hospital mortality and adverse outcomes in moderate-to severe COVID-19 patients, irrespective of pre-existing glycemic status.
    Mondal S; DasGupta R; Lodh M; Garai R; Choudhury B; Hazra AK; Mondal A; Ganguly A
    Diabetes Res Clin Pract; 2022 Aug; 190():109974. PubMed ID: 35809688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
    Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
    Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is elevated blood glucose at admission associated with poor outcomes in hospitalized COVID-19 patients?
    Barbosa M; Marques-Sá J; Carvalho C; Fernandes V
    Arch Endocrinol Metab; 2023 Jun; 67(6):e000649. PubMed ID: 37364151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of newly diagnosed diabetes on coronavirus disease 2019 severity and hyperglycemia.
    Uchihara M; Bouchi R; Kodani N; Saito S; Miyazato Y; Umamoto K; Sugimoto H; Kobayashi M; Hikida S; Akiyama Y; Ihana-Sugiyama N; Ohsugi M; Tanabe A; Ueki K; Takasaki J; Hojo M; Kajio H
    J Diabetes Investig; 2022 Jun; 13(6):1086-1093. PubMed ID: 35075818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia is Associated With Increased Mortality in Critically Ill Patients With COVID-19.
    Mazori AY; Bass IR; Chan L; Mathews KS; Altman DR; Saha A; Soh H; Wen HH; Bose S; Leven E; Wang JG; Mosoyan G; Pattharanitima P; Greco G; Gallagher EJ
    Endocr Pract; 2021 Feb; 27(2):95-100. PubMed ID: 33551315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Study of Hyperglycemia and SARS-CoV-2 Infection in Intensive Care Unit Patients.
    Ilias I; Jahaj E; Kokkoris S; Zervakis D; Temperikidis P; Magira E; Pratikaki M; Vassiliou AG; Routsi C; Kotanidou A; Dimopoulou I
    In Vivo; 2020; 34(5):3029-3032. PubMed ID: 32871848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and diabetes: A bidirectional relationship.
    Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
    Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between D-dimer levels in diabetic and non-diabetic positive COVID-19 adult patients: A hospital-based study.
    Hashim Ibrahim Elbashir I; Kamal Ali Mohamed H; Adam Essa ME; Seri A
    Endocrinol Diabetes Metab; 2022 Jul; 5(4):e349. PubMed ID: 35614558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.
    Li H; Tian S; Chen T; Cui Z; Shi N; Zhong X; Qiu K; Zhang J; Zeng T; Chen L; Zheng J
    Diabetes Obes Metab; 2020 Oct; 22(10):1897-1906. PubMed ID: 32469464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress-Induced and Diabetic Hyperglycemia Associated with Higher Mortality among Intensive Care Unit Trauma Patients: Cross-Sectional Analysis of the Propensity Score-Matched Population.
    Chang MW; Huang CY; Liu HT; Chen YC; Hsieh CH
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29762485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic Dysregulation, Inflammation and Disease Outcomes in Patients Hospitalized with COVID-19: Beyond Diabetes and Obesity.
    Liontos A; Biros D; Kavakli A; Matzaras R; Tsiakas I; Athanasiou L; Samanidou V; Konstantopoulou R; Vagias I; Panteli A; Pappa C; Kolios NG; Nasiou M; Pargana E; Milionis H; Christaki E
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19.
    Calvisi SL; Ramirez GA; Scavini M; Da Prat V; Di Lucca G; Laurenzi A; Gallina G; Cavallo L; Borio G; Farolfi F; Pascali M; Castellani J; Lampasona V; D'Angelo A; Landoni G; Ciceri F; Querini PR; Tresoldi M; Piemonti L
    Metabolism; 2021 Oct; 123():154845. PubMed ID: 34364927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study.
    Li Y; Han X; Alwalid O; Cui Y; Cao Y; Liu J; Gu J; Wang L; Fan Y; Shi H
    Diabetes Res Clin Pract; 2020 Aug; 166():108299. PubMed ID: 32623030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.